Postmenopausal women with moderate to severe vasomotor symptoms were randomly assigned to paroxetine 7.5 mg ( n = 591 ) or placebo ( n = 593 ) once daily for 12 weeks ( both studies ) or 24 weeks ( 24-wk study ) .